CX-5461 recently progressed through phase I clinical trial as a first-in-human inhibitor of RNA-POL I.
Domain | cx-5461inhibitor.com |
---|---|
Homepage URL | https://cx-5461inhibitor.com/improved-β-site-app-cleaving-molecule-1-mediated-insulin-receptor-cleavage-in/ |
Keywords | cx-5461 inhibitor signaling pathway biophysics |
Sprache | englisch |